Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Naloxone alters pain perception and somatosensory evoked potentials in normal subjects

Abstract

THE discovery of opiate-like peptides (endorphins) in brain, blood and cerebrospinal fluid1–4 raises questions as to the physiological role of these substances. Given the prominent analgesic effects of opiates, the regulation of pain perception is a candidate for endorphin action. Endorphins microinjected into the periacqueductal grey matter of rats induce analgesia which is reversed by naloxone, a pure narcotic antagonist5. If endorphins play an active part in the regulation of pain, then naloxone administered to man should alter pain appreciation. Naloxone has not been shown to have analgesic, respiratory, euphoric, pupillary or electroencephalogram (EEG) effects in man6. Studies in rats7,8 and one early study in man9 have suggested slight hyperalgesic effects with naloxone. El-Sobky et al.10 failed to demonstrate naloxone effects on electric shock pain judgments in five subjects. In the experiments reported here, subjects were divided into pain sensitive and pain insensitive subgroups. The insensitive subjects found shocks significantly more painful after naloxone administration while the sensitive group experienced them as less painful. Evoked potentials showed similar significant group differences. These results suggest that individual differences in pain sensitivity may relate to differences in an endorphin system.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hughes, J. Brain Res. 88, 259–308 (1975).

    Article  ADS  Google Scholar 

  2. Terenius, L. & Wahlstrom, A. Life Sci. 16, 1759–1764 (1975).

    Article  CAS  Google Scholar 

  3. Frederickson, R., Schirmer, E. W., Grinnan, E. L., Harrell, C. W. & Hewes, C. R. Life Sci. 19, 1181–1184 (1976).

    Article  CAS  PubMed  Google Scholar 

  4. Pert, C. B., Pert, A. & Tallman, J. F. Proc. natn. Acad. Sci. U.S.A. 73, 2226–2230 (1976).

    Article  ADS  CAS  Google Scholar 

  5. Pert, A. in Opiates and Endogenous Opioid Peptides 87–94 (Elsevier, North Holland, New York, 1976).

    Google Scholar 

  6. Jasinski, D. R., Martin, W. R. & Haertzen, C. A. J. Pharmac. exp. Ther. 157, 420–426 (1967).

    CAS  Google Scholar 

  7. Jacob, J. J., Tremblay, E. C. & Colombel, M. C. Psychopharmacologia (Berl.) 37, 217–223 (1974).

    Article  CAS  Google Scholar 

  8. Frederickson, R. C. A., Nickander, R., Smithwick, E. C., Shuman, R. & Norris, F. H. in Opiates and Endogenous Opioid Peptides 239–246 (Elsevier North Holland, New York, 1976).

    Google Scholar 

  9. Lasagna, L. Proc. R. Soc. Med. 58, 978–983 (1965).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. El-Sobky, A., Dostrovsky, J. D. & Wall, P. D. Nature 263, 783–784 (1976).

    Article  ADS  CAS  PubMed  Google Scholar 

  11. Tursky, B. Psychophysiology 11, 95–112 (1974).

    Article  CAS  PubMed  Google Scholar 

  12. Sitaram, N., Buchsbaum, M. S. & Gillin, J. C. Eur. J. Pharm. 42, 285–290 (1977).

    Article  CAS  Google Scholar 

  13. Lavine, R., Buchsbaum, M. S. & Poncy, M. Psychophysiology 13, 140–148 (1976).

    Article  CAS  PubMed  Google Scholar 

  14. Chapman, C. R., Murphy, T. M. & Butler, S. H. Science 179, 1246–1248 (1972).

    Article  ADS  Google Scholar 

  15. Clark, W. C. & Goodman, J. S. J. Abnormal Psych. 83, 364–372 (1974).

    Article  CAS  Google Scholar 

  16. Buchsbaum, M. S. in Biology of the Major Psychoses: A comparative Analysis 129–142 (Raven, New York, 1975).

    Google Scholar 

  17. Leybin, L., Pinsky, C., Labella, F. S., Havelicek, V. & Rezek, M. Nature 264, 458–459 (1976).

    Article  ADS  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

BUCHSBAUM, M., DAVIS, G. & BUNNEY, W. Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature 270, 620–622 (1977). https://doi.org/10.1038/270620a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/270620a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing